The lipophilic amines dimethyl dioctadecyl ammonium bromide (DDA) and N,iVdioctadecyl-N:N'-bis(2-hydroxyethyl)propanediamine 961) are compared on their capacities to induce interferon, nonspecific protection to viral infection, and enhancement of delayed-type hypersensitivity (DH). DDA, a well-known adjuvant for the induction of DH is a moderate interferon inducer like CP-20,96 1. On the other hand, CP-20.96 1, a known interferon inducer and resembling in structure DDA, is shown to enhance DH to inactivated Semliki Forest virus (WV). Nonspecific protection to challenge with a lethal dose of either SFV or encephalomyocarditis (EMC) virus was induced on injection of both compounds.